Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Bradyarrhythmia

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Bradyarrhythmia in 2 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, MT1
Chueh, FY1
Hsieh, MT1
Chen, CF1
N'Diaye, A1
Sévoz-Couche, C1
Nosjean, A1
Hamon, M1
Laguzzi, R1

Other Studies

2 other studies available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Bradyarrhythmia

ArticleYear
Antihypertensive effects of DL-tetrahydropalmatine: an active principle isolated from Corydalis.
    Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:8

    Topics: Amphetamines; Analysis of Variance; Animals; Antihypertensive Agents; Berberine Alkaloids; Blood Pre

1996
Stimulation of 5-HT2 receptors in the nucleus tractus solitarius enhances NMDA receptor-mediated reflex-evoked bradycardiac responses in the rat.
    Autonomic neuroscience : basic & clinical, 2001, Sep-17, Volume: 92, Issue:1-2

    Topics: 2-Amino-5-phosphonovalerate; Amphetamines; Anesthesia; Animals; Blood Pressure; Bradycardia; Chemore

2001